
معرفی
Soizic Chevance is an Assistant Professor at the University of Rennes, affiliated with the Institut des Sciences Chimiques de Rennes (ISCR UMR CNRS 6226) and serves as the Scientific Manager of the BioNMR platform within the PRISM infrastructure. She is based at Campus Santé, Building 5, Office 928 in Rennes, France. Her research integrates chemistry, nanotechnology, and biology to explore functional nanomaterials and their biomedical applications.
- Academic Rank: Assistant Professor
- Research Unit: Institut des Sciences Chimiques de Rennes (ISCR), UMR CNRS 6226
- Platform: PRISM Bio-NMR
- Email: soizic.chevance@univ-rennes.fr
- Phone: +33 (0)2 23 23 56 49
- ORCID: 0000-0001-9699-5943
Dr. Chevance holds a PhD in Structural Biology from the University of Rennes 1 (2001–2004), supervised by Dr. Arnaud Bondon, and completed a postdoctoral fellowship at the University of Florence, Italy (2005–2007). She began her academic career as a Research Engineer at the Institute of Genetics and Development of Rennes in 2008 before becoming an Assistant Professor at University of Rennes 1, a role she continues in at the current University of Rennes since 2021.
Her research spans nanoparticles and functional self-assemblies, with applications in theranostics and advanced materials. She investigates the toxicity of nanoparticles through the ANR Solnanotox project and examines interactions involving biomolecules such as peptides, drugs, and biomimetic membranes. A key focus is bioconjugation and aqueous-phase catalysis using porphyrins, contributing to green and sustainable chemistry. She also studies the conformational stability and electron transfer in hemoproteins within ionic liquids, bridging biophysics and materials science. Her technical expertise includes Liquid NMR, CD, FTIR, fluorescence, DLS, NTA, DSC, and ITC.
The most recent publications reveal a consistent focus on nanomedicine, structural biology, and green catalysis. Her work connects fundamental molecular interactions with practical applications in health and materials. Notably, her 2019 review on 13C-13C NOESY in bioinorganic chemistry highlights advanced NMR techniques, while her 2017 review on nanoparticles in CAR-T cell therapy underscores translational research. Earlier works on porphyrin catalysis and cyclopropanation in water emphasize sustainable synthetic methodologies.
Scientific Awards and Recognition:
- No formal scientific awards are explicitly mentioned in the provided text.
Dr. Chevance is deeply involved in academic service and mentoring. She has co-directed a PhD student (Marie-Laure Pinel-Marie, 2020–2023) and is actively engaged in teaching across multiple programs. She holds leadership roles in curriculum development and has significant committee responsibilities, including serving on the Administration Council of UR1, the ISCR board regent, and as a professional equality referent. She has not received specific grants mentioned in the text, but her involvement in ANR-funded projects indicates competitive research funding.
She leads the BioNMR platform within PRISM, a core facility supporting structural biology and nanomaterial characterization. She collaborates with institutions such as INSERM, Biotrial, CRAN, and CHU Metz-Thionville on projects like PCSI GOLD, which explores combined chemo-/radio-therapy using gold nanoparticles. These collaborations integrate physics, oncology, and chemistry for innovative cancer treatments.





